Aerius D-12 Modified Release Tablets 2.5mg/120mg
Product details
Registration number: SIN13772P
Classification: Prescription Only
Active ingredients:
- (IR Layer) Desloratadine, Micronized
- (SR Layer) Pseudoephedrine sulfate
Strength:
- 2.5mg
- 120.0mg
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Registrant: ORGANON SINGAPORE PTE. LTD.
ATC code: R01BA52
HSA approval date: 5 March 2010
Manufacturer(s): Patheon Inc., Whitby Operations
Manufacturing country/countries: CANADA
What are the HSA registration number and classification for Aerius D-12 Modified Release Tablets 2.5mg/120mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13772P
Classification: Prescription Only
What active ingredients and strength are recorded for Aerius D-12 Modified Release Tablets 2.5mg/120mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- (IR Layer) Desloratadine, Micronized
- (SR Layer) Pseudoephedrine sulfate
Strength:
- 2.5mg
- 120.0mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Aerius D-12 Modified Release Tablets 2.5mg/120mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Who is the recorded registrant for Aerius D-12 Modified Release Tablets 2.5mg/120mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ORGANON SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Aerius D-12 Modified Release Tablets 2.5mg/120mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Patheon Inc., Whitby Operations
Manufacturing country/countries: CANADA
Where can I look up Aerius D-12 Modified Release Tablets 2.5mg/120mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13772P or the exact product name Aerius D-12 Modified Release Tablets 2.5mg/120mg. The general register link does not preselect this product.
What are the source dates for this Aerius D-12 Modified Release Tablets 2.5mg/120mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Aerius D-12 Modified Release Tablets 2.5mg/120mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13772P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)